quinta-feira, 5 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document

How and When the Memory Chip Shortage Will End

View original at spectrum.ieee.org
IEEE Spectrum - Technical Title: How and When the Memory Chip Shortage Will End Date: 2026-02-10 14:00 Source: https://spectrum.ieee.org/dram-shortage <img src="https://spectrum.ieee.org/media-library/sk-hynix-inc-s-12-layer-hbm4-memory-chips-on-display.jpg?id=63918122&width=1245&height=700&coordinates=0%2C187%2C0%2C18…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Companies will spend $7 trillion on data centers by 2030, with $5.2 trillion going to AI-focused data centers, of which $3.3 billion will go toward servers, data storage, and network equipment.

    80% confidence
  • In general, economists find that prices come down much more slowly and reluctantly than they go up. DRAM today is unlikely to be an exception, especially given the insatiable demand for compute.

    80% confidence
  • HBM generally costs three times as much as other types of memory and constitutes 50 percent or more of the cost of the packaged GPU.

    80% confidence
  • Relief will come from a combination of incremental capacity expansions by existing DRAM leaders, yield improvements in advanced packaging, and a broader diversification of supply chains. New fabs will help at the margin, but the faster gains will come from process learning, better DRAM stacking efficiency, and tighter coordination between memory suppliers and AI chip designers.

    80% confidence
  • There are two ways to address supply issues with DRAM: with innovation or with building more fabs. As DRAM scaling has become more difficult, the industry has turned to advanced packaging, which is just using more DRAM.

    80% confidence
  • DRAM is a highly cyclical industry with huge booms and devastating busts. With new fabs costing $15 billion or more, firms are extremely reluctant to expand and may only have the cash to do so during boom times. Building a fab and getting it up and running can take 18 months or more, practically ensuring that new capacity arrives well past the initial surge in demand.

    80% confidence
  • Micron predicts the total market for HBM will grow from $35 billion in 2025 to $100 billion by 2028, a figure larger than the entire DRAM market in 2024, reached two years earlier than previously expected. Demand will outstrip supply substantially for the foreseeable future.

    80% confidence
  • There will be no relief in the DRAM market until 2028.

    80% confidence
  • There are nearly 2,000 new data centers either planned or under construction globally, representing a potential 20 percent jump in global supply from the current approximately 9,000 facilities.

    80% confidence
  • DRAM prices have risen 80-90 percent so far this quarter (Q1 2026).

    80% confidence
  • The origins of today's DRAM cycle go back to the chip supply panic surrounding COVID-19. Hyperscalers bought up huge inventories of memory and storage to avoid supply-chain stumbles and support the rapid shift to remote work, boosting prices.

    80% confidence
  • After a recovery began in late 2023, all the memory and storage companies were very wary of increasing their production capacity again, resulting in little or no investment in new production capacity in 2024 and through most of 2025.

    80% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,549 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
How and When the Memory Chip Shortage Will End — Source | Via News | pt.VIA.NEWS